9 Meters Biopharma Inc (NMTR) WACC Analysis

As of May 25, 2025, 9 Meters Biopharma Inc (NMTR) carries a Weighted Average Cost of Capital (WACC) of 5.4%. WACC reflects the blended rate 9 Meters Biopharma Inc must pay to both equity and debt holders.

Within that, the cost of equity is 8.9%, the cost of debt is 5.0%, and the effective tax rate is 26.2%.

Breakdown of WACC Components

• Long-term bond rate: 4.2% – 4.7%
• Equity market risk premium: 5.0% – 6.0%
• Adjusted beta: 0.94 – 1.28
• Additional risk adjustment: 0.0% – 0.5%
• Debt-to-equity ratio: 3.05

What It Means for Investors

With a selected WACC of 5.4%, 9 Meters Biopharma Inc must ensure any new investment returns exceed this threshold to generate shareholder value. This level reflects an attractive low cost of capital.